The impacts of post-COVID neuropsychiatric symptoms on survivors' workability

• Grant number: 22/04232-2
• Support Opportunities: Scholarships in Brazil - Scientific Initiation
• Start date: July 01, 2022
• End date: June 30, 2024
• Field of knowledge: Health Sciences - Medicine - Medical Clinics
• Principal Investigator: Clarissa Lin Yasuda
• Grantee: Gabriel Monteiro Salvador
• Host Institution: Faculdade de Ciências Médicas (FCM). Universidade Estadual de Campinas (UNICAMP). Campinas , SP, Brazil
• Associated research grant: 13/07559-3 - BRAINN - The Brazilian Institute of Neuroscience and Neurotechnology, AP.CEPID

Abstract

The persistence of viral symptoms in COVID-19 survivors is being widely discussed with the literature advancing in recognizing these sequelae. The reported neurological complications are identified in moderate manifestations of headache, fatigue, and muscle pain. As well as acute manifestations of encephalopathies. these sequelae promote a loss in the quality of life of patients, reflecting on their general state of disposition, work and social life. Persistence of symptoms of fatigue, anxiety and sleep disorders are evidenced in studies. The post-infection implications of SARS-CoV-2 on the work capacity of survivors are expected, however, they still remain uncertain for effective rehabilitation measures. In the Brazilian scenario, there is a lack of longitudinal studies that monitor patients who survive COVID-19, focusing on the complications of neuropsychiatric symptoms in the ability to work. Objective: To collect epidemiological data about persistent neuropsychiatric deficits, cognitive dysfunctions and changes in work capacity in patients surviving COVID-19 at Clinical Hospital of State University of Campinas in the period 2020-2022. Participants and methods: For this longitudinal study, 150 patients diagnosed with COVID-19 will be used as a sample group. The selection of participants will be carried out by collecting information acquired in the online form of the Neurocovid Study - UNICAMP, in progress since July 2020. No exclusivity of gender, race or symptomatic condition of the infection. Thus, in the case of a longitudinal study, to quantify changes in work capacity in patients exposed to COVID-19 during the application of two questionnaires that measure such variables.(AU)